Title |
The high comorbidity burden of the hepatitis C virus infected population in the United States
|
---|---|
Published in |
BMC Infectious Diseases, April 2012
|
DOI | 10.1186/1471-2334-12-86 |
Pubmed ID | |
Authors |
Karly S Louie, Samantha St Laurent, Ulla M Forssen, Linda M Mundy, Jeanne M Pimenta |
Abstract |
Chronic hepatitis C (HCV) disease can be complicated with comorbid conditions that may impact treatment eligibility and outcomes. The aim of the study was to systematically review comorbidities and symptoms in an HCV infected population, specifically assessing comorbidities associated with HCV anti-viral treatment and disease, as well as comparing comorbidities between an HCV infected and uninfected control population. |
X Demographics
The data shown below were collected from the profiles of 6 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 2 | 33% |
Spain | 1 | 17% |
Australia | 1 | 17% |
Unknown | 2 | 33% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 6 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 93 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Spain | 1 | 1% |
Denmark | 1 | 1% |
Unknown | 91 | 98% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Researcher | 15 | 16% |
Student > Master | 11 | 12% |
Student > Bachelor | 11 | 12% |
Student > Postgraduate | 10 | 11% |
Other | 8 | 9% |
Other | 21 | 23% |
Unknown | 17 | 18% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 37 | 40% |
Agricultural and Biological Sciences | 11 | 12% |
Nursing and Health Professions | 5 | 5% |
Social Sciences | 3 | 3% |
Economics, Econometrics and Finance | 3 | 3% |
Other | 10 | 11% |
Unknown | 24 | 26% |
Attention Score in Context
This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 27 April 2012.
All research outputs
#7,313,982
of 22,664,267 outputs
Outputs from BMC Infectious Diseases
#2,483
of 7,636 outputs
Outputs of similar age
#52,547
of 161,627 outputs
Outputs of similar age from BMC Infectious Diseases
#24
of 95 outputs
Altmetric has tracked 22,664,267 research outputs across all sources so far. This one has received more attention than most of these and is in the 67th percentile.
So far Altmetric has tracked 7,636 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 9.6. This one has gotten more attention than average, scoring higher than 67% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 161,627 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 67% of its contemporaries.
We're also able to compare this research output to 95 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 74% of its contemporaries.